A randomized crossover trial comparing the efficacy and safety of tiotropium + procaterol versus tiotropium + placebo in moderate COPD [chronic obstructive pulmonary disease] patients.

Trial Profile

A randomized crossover trial comparing the efficacy and safety of tiotropium + procaterol versus tiotropium + placebo in moderate COPD [chronic obstructive pulmonary disease] patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2009

At a glance

  • Drugs Procaterol; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 22 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 16 May 2008 The expected completion date for this trial is now 1 Apr 2008.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top